New drug could keep stents open after stroke, reducing need for rescue therapy
NCT ID NCT06813651
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called TBO-309 in 78 people having a stroke caused by a blocked artery in the neck and brain. The drug is given through a vein during standard clot-removal and stenting procedures. The goal is to see if TBO-309 can keep the stent open without causing dangerous bleeding in the brain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John Hunter Hospital
RECRUITINGNewcastle, New South Wales, 2305, Australia
-
Royal North Shore Hospital
NOT_YET_RECRUITINGSt Leonards, New South Wales, 2065, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore swallowing after stroke?
- Can Brain-Triggered stimulation reawaken arms after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Can Clot-Removing devices improve stroke recovery?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Can virtual games retrain the brain to restore balance?